GEODIS has signed an agreement to acquire trans-o-flex, a premium express delivery company in Germany, specialized in temperature-controlled transport for pharmaceutical products as well as in time-definite delivery of products for cosmetics and high-tech industries.
Since 2016, the company has been owned by the families of Schoeller and Amberger, who have invested to scale it up to a leading specialized distribution player.
“The acquisition of trans-o-flex is a key step forward enabling us to increase our footprint in Germany. It is consistent with our ambition to strengthen our global end-to-end logistics solutions to support our customers’ growth and geographic development. This acquisition will position GEODIS as a leading player in the healthcare market and will significantly enhance our delivery capabilities in Germany, a country at the heart of global trade,” said Marie-Christine Lombard, Chief Executive Officer of GEODIS.
Founded in 1971, trans-o-flex operates Germany’s largest temperature-controlled distribution network specializing in healthcare, handling both parcels and pallets.
Trans-o-flex is headquartered in Germany and has recently expanded its activity in Austria, which offers opportunities for further development. The company employs around 2,000 people across 77 hubs and local agencies which enables the company to offer Express logistics solutions throughout Germany.
Christoph Schoeller and Peter Amberger, representatives of the shareholders, said:
“Since we acquired trans-o-flex in 2016, the company has further established its leadership in the temperature-controlled healthcare and premium Express delivery through its widely-recognized quality network and its high reliability of service throughout Germany and Austria.”
Christoph Schoeller himself added:
“I am glad to be part of the continuation of the success story of trans-oflex as vice-chairman of the supervisory board. Together with GEODIS, we will scale the trans-o-flex model internationally and thus further increase the benefits for our customers.
The closing of this deal will be effective after the completion of the usual regulatory approvals.